KARYOPHARM SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Aga...

NEW ORLEANS, July 26, 2019 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have untilSeptember 23, 2019 to file lead plaintiff applications in a securities class action lawsuit against Karyopharm Therapeutics Inc. (NasdaqGS: KPTI), if they purchased the Company's shares issued in connection with its April 2017 or May 2018 public offering or between March 2, 2017 and February 22, 2019, inclusive (the "Class Period").  This action is pending in the United States District Court for the District of Massachusetts.

What You May Do

If you purchased shares of Karyopharm and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nasdaqgs-kpti/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by September 23, 2019.

About the Lawsuit

Karyopharm and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. 

On February 22, 2019, the Federal Drug Administration ("FDA") reported serious concerns with the Company's drug, selinexor. Specifically, the FDA concluded that, contrary to the Company's prior assurances, "[t]reatment with selinexor is associated with significant toxicity" with "limited efficacy."

On this news, the price of Karyopharm's shares plummeted.

The case is Allegheny County Employees' Retirement System v. Karyopharm Therapeutics Inc., 1:19-cv-11597.

About Kahn Swick & Foti, LLC

KSF, whose partners include the former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850
1100 Poydras St., Suite 3200
New Orleans, LA 70163

View original content to download multimedia:http://www.prnewswire.com/news-releases/karyopharm-shareholder-alert-by-former-louisiana-attorney-general-kahn-swick--foti-llc-reminds-investors-with-losses-in-excess-of-100-000-of-lead-plaintiff-deadline-in-class-action-lawsuit-against-karyopharm-therapeutics-inc--300891917.html

SOURCE Kahn Swick & Foti, LLC